Monitoring of tissue polypeptide specific antigen in the treatment for advanced cancers and its significance / 中国癌症杂志
China Oncology
; (12)2001.
Article
en Zh
| WPRIM
| ID: wpr-675448
Biblioteca responsable:
WPRO
ABSTRACT
Purpose:To determine the impact of serum tissue polypeptide specific antigen (TPS) in the treatment for advanced cancer patients. Methods:Serum TPS was examined in 60 advanced cancer cases. 42 of the patients received hepatic arterial chemoembolization or chemotherapy. For those with tumors derived from digestive system, TPS monitoring was performed in serial during the therapeutic courses. Results:No significant differentiation was observed in terms of age, gender, disease or tumor stage. Patients with initial TPS lower than 300 U/L had the most favorable response rate to treatment (PR,CR or MR) of 52.94%, while those with initial TPS higher than 1000 U/L showed no evidence of remission after therapy. 55.56% of the latter developed into PD ( P
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
China Oncology
Año:
2001
Tipo del documento:
Article